Procuro Sanitizing Wet Wipes - Lemon Fragrance

Benzalkonium Chloride


Dongguan Pharmapack Fulibao Personal Care Products Ltd
Human Otc Drug
NDC 77243-108
Procuro Sanitizing Wet Wipes - Lemon Fragrance also known as Benzalkonium Chloride is a human otc drug labeled by 'Dongguan Pharmapack Fulibao Personal Care Products Ltd'. National Drug Code (NDC) number for Procuro Sanitizing Wet Wipes - Lemon Fragrance is 77243-108. This drug is available in dosage form of Cloth. The names of the active, medicinal ingredients in Procuro Sanitizing Wet Wipes - Lemon Fragrance drug includes Benzalkonium Chloride - .13 g/100mL . The currest status of Procuro Sanitizing Wet Wipes - Lemon Fragrance drug is Active.

Drug Information:

Drug NDC: 77243-108
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Procuro Sanitizing Wet Wipes - Lemon Fragrance
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Benzalkonium Chloride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Dongguan Pharmapack Fulibao Personal Care Products Ltd
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cloth
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:BENZALKONIUM CHLORIDE - .13 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 07 Oct, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 22 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333A
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Dongguan Pharmapack Fulibao Personal Care Products Ltd
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1038558
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:F5UM2KM3W7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
77243-108-14100 PACKAGE in 1 CANISTER (77243-108-14) / 4 mL in 1 PACKAGE07 Oct, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antimicrobial

Product Elements:

Procuro sanitizing wet wipes - lemon fragrance benzalkonium chloride water propylene glycol glycerin cetylpyridinium chloride polyoxyl 40 hydrogenated castor oil aloe vera leaf .alpha.-tocopherol acetate dimethicone glyceryl monostearate polysorbate 60 silicon dioxide croscarmellose potassium sorbate benzalkonium chloride benzalkonium

Indications and Usage:

Use • sanitizing wipe to help reduce bacteria

Warnings:

Warnings for external use only when using this product do not use in or near the eyes. in case of contact, rinse eyes thoroughly with water. stop use and ask a doctor if irritation or rash appears and lasts keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.

Dosage and Administration:

Directions • wet hands thoroughly with product and allow to dry • children should be supervised when using this product.

Package Label Principal Display Panel:

Packaging image description image description


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.